BEAM vs TFC · rev $63.5M vs rev $24.54B
Beam Therapeutics Inc (BEAM) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
BEAM currently screens at market cap $2.01B. TFC currently screens at market cap $0.
Not investment advice. Open the BEAM and TFC stock pages for the full models.
Not investment advice.